News

The study was conducted by ViRexx’s licensing partner, Unither Pharmaceuticals, a subsidiary of United Therapeutics Corporation. Patients with newly diagnosed advanced ovarian cancer were treated by surgery and

The study was a randomized, single-center, single-dose, six-period pilot study to evaluate four SmartRelief prototypes. The study compared sumatriptan pharmacokinetics and safety following administration of NP101 SmartRelief prototype

The lawsuit alleges that Dr Picker breached his written employment agreement with Callisto by accepting employment with Tapestry Pharmaceuticals in a manner not in accordance with his agreement.

<p>The so-called Study 102 showed that Viread is non-inferior to the company&#0039;s once-daily antiviral drug Hepsera among patients with chronic hepatitis B virus (HBV) infection. The primary efficacy

Zetia is the first new cholesterol-lowering medication with a novel mechanism of action since statins were introduced 18 years ago in Japan, according to the companies. The drug

Nimotuzumab is a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). The single-arm trial, which will enroll approximately 40 patients, will be initiated shortly in

Humira is the first self-administered biologic for the treatment of Crohn’s disease and offers an effective and convenient treatment option that can help enable patients to maintain control

Conventional therapies in this indication include corticosteroids, immunomodulators and primary nutrition therapy. The approval follows a positive opinion granted in March by the Committee for Medicinal Products for

The settlement, which is covered in its entirety by Pharmos’ insurance, has been reached with no admission of liability by any party, the New Jersey-based company said. Pharmos